HealthSmart's FDA chat defines your snack bar's 'net carbs
HealthSmart met with FDA regulators over low-carb food labeling, reopening a 22-year-old federal debate over what claims belong on your grocery store packaging.
By Foodie Pundit Newsroom - Published - Updated - Section: Desserts Snacks

Key points
- HealthSmart Foods, a maker of low-carb products, met with the FDA to discuss nutrition labeling rules.
- The FDA has the ultimate authority to decide how nutritional claims like "net carbs" are defined and used on food packaging.
- The meeting is a direct example of a regulated company seeking to influence the rules it profits from.
- The public record of the meeting does not detail any financial transactions or guarantee any change in policy.
- The next thing to watch is whether the FDA takes any action on the long-standing regulatory docket related to this issue.
You are standing in the grocery store, staring at a wall of snack bars. Your eyes glaze over the packaging, a chaotic mosaic of promises. One bar screams "1g Sugar."
Another boasts "Keto Certified." A third, in bold letters, declares "Only 5g Net Carbs." You grab the "net carbs" bar, trusting the front of the box.
That trust relies on an invisible contract whose terms are actively negotiated in quiet Washington meeting rooms under the Trump administration. Who defines 'net carbs'?
Who gets to define "net carbs"? Is it a scientifically rigorous measurement or a marketing term designed to sell another protein bar? The answer is being shaped not in a laboratory, but in federal regulations.
The paper trail is often thin, buried in public dockets that few people read. A single document summarizing a meeting can illuminate the entire process. It shows who is asking for changes to the rules, what they stand to gain, and how the language of food is forged between corporate interest and public health. The Beneficiary
HealthSmart Foods, Inc. is the company seeking to influence the rules, and it stands to benefit directly. According to a federal memo, its representatives met with regulators to discuss carbohydrate labeling. HealthSmart operates in a specific corner of the food world: products designed for low carbohydrate and ketogenic lifestyles.
Its portfolio centers on protein bars, shakes, and snacks where the primary selling point is the manipulation of the carbohydrate count. Its business model depends on consumer belief in products that fit this nutritional framework.
For a company like HealthSmart, the term "net carbs" is everything. It is the key that unlocks a market of health-conscious consumers, people with diabetes, and ketogenic diet followers. Currently, "net carbs" has no official, legally binding definition from the Food and Drug Administration.
It is an industry term, generally calculated by taking total carbohydrates and subtracting dietary fiber and certain sugar alcohols. The theory is that these subtracted components have a minimal impact on blood sugar.
This lack of a formal definition presents both an opportunity and a risk for HealthSmart. The freedom allows the company to use the calculation that best suits its products. The risk is that the FDA could crack down on the term, or a competitor could use a different calculation, sowing consumer confusion and eroding the value of the claim.
Getting the FDA to formalize a definition of "net carbs" that aligns with its existing products would be a major victory. It would bestow a government seal of approval on its marketing, create a barrier to entry for competitors who cannot meet that standard, and solidify its position in the market. The Deciding Authority
The authority to define terms like "net carbs" rests with the Food and Drug Administration. Specifically, federal records show the meeting involved officials from the FDA's Center for Food Safety and Applied Nutrition, known as CFSAN, and its internal Office of Nutrition and Food Labeling. This office holds the power over the outcome. It is responsible for developing, reviewing, and enforcing the policies and regulations for how food is labeled in the United States.
The rules this office writes carry the force of law under the Code of Federal Regulations. The Office of Nutrition and Food Labeling determines what can appear on a Nutrition Facts panel, and it sets the specific criteria for nutrient content claims made on the front of a package.
If the FDA decides to create a legal definition for "net carbs," this office will write that definition. Its decision will dictate the formulation and marketing of thousands of products sold across the country. The Point of Contact
Federal records show a direct overlap between the beneficiary and the decider. On August 7, 2026, the regulated entity, HealthSmart Foods, met with its regulator, the FDA's Office of Nutrition and Food Labeling. According to the official memo of the meeting, the explicit topic was the agency's policies on nutrient content claims and carbohydrate labeling.
The company that profits from the "net carbs" claim petitioned the specific government office that holds the authority to legitimize that claim as an official, legally defined term. The point of contact is the regulatory process itself. A Two Decade Timeline
The story of this regulatory push is defined by its long timeline, visible in the federal docket system. The sequence of events demonstrates how long industry and government have been grappling with this issue.
The official file for this matter, docket number FDA-2004-P-0021, was opened by the Food and Drug Administration in 2004. The "P" in the docket number signifies a petition, showing the process was initiated by an outside party asking the agency to make, change, or revoke a rule.
More than two decades after that petition was first filed, the issue remains unresolved. The August 7, 2026, meeting between HealthSmart Foods and the FDA is the most recent documented event in this regulatory record. This meeting, memorialized in a "Memo to the File" and made public on the Regulations.
gov portal, occurred over 22 years after the initial petition was filed. The memo's existence confirms that the effort to define carbohydrate claims remains an active concern for industry players and federal regulators. The timeline establishes that HealthSmart's engagement is the latest step in a process spanning multiple presidential administrations. The Official Figures
The federal records available for this matter do not contain financial data such as contract values, lobbying expenditures, or grant awards.
The one key figure the official memo provides is the docket number assigned by the Food and Drug Administration: FDA-2004-P-0021. This filing number acts as the unique government identifier for the administrative record related to the original 2004 petition on carbohydrate labeling. Every public comment, meeting memo, scientific submission, and agency decision related to this regulatory question is collected under this number. It is the official tracking figure for a process active for more than 20 years. What the Record Proves and Does Not
The federal paper trail establishes a limited set of facts and does not provide proof of wrongdoing. An activity record, such as a meeting memo or a lobbying filing, is not evidence of an illegal act, a quid pro quo, or undue influence. It is a documented account of a legal part of the federal regulatory process.
The "Memo to the File" from the Food and Drug Administration proves several facts. It establishes that a meeting took place on August 7, 2026. It proves who attended: representatives from HealthSmart Foods, Inc. met with officials from the FDA's Center for Food Safety and Applied Nutrition and its Office of Nutrition and Food Labeling.
It proves the subject of the meeting was the agency's policies regarding nutrient content claims and the labeling of carbohydrates. Finally, it proves this meeting is part of the public record for docket FDA-2004-P-0021.
The record does not prove that HealthSmart's arguments were successful or that the FDA was swayed. It does not reveal the specifics of the conversation beyond the general topic. The memo does not indicate whether the FDA made any commitments or agreed to any of HealthSmart's positions.
The document does not provide evidence of any agreement, payment, or improper coordination between the company and the agency. The meeting represents a standard procedure where regulated industries present their views to the agencies that oversee them. The crowded keto market
This regulatory push takes place in the crowded wellness food market. Walk down the aisles of Whole Foods, Target, or a conventional supermarket, and you will see shelves packed with high-protein and low-carb items. It is a multibillion-dollar industry fueled by social media trends, diet culture, and consumer demand for healthier options.
HealthSmart is just one resident in this market. Legacy food giants are adapting high-sugar products with low-carb line extensions. Hundreds of startups and direct-to-consumer brands compete for shelf space and social media placements, each using custom blends of sweeteners and fibers to lower carb counts.
Other powerful voices are involved in this conversation. Public health advocates and consumer watchdog groups argue that terms like "net carbs" can be misleading, creating a halo effect around processed foods. They petition the FDA for stricter rules and greater clarity, arguing that these calculations encourage consumers to ignore the overall nutritional quality of a product. Medical associations also weigh in, concerned about the impact of these foods on patients managing diabetes.
The FDA sits in the middle, tasked with refereeing this debate. The agency operates under a dual mandate: to protect public health and to facilitate commerce and innovation in the food industry. Regulators balance nutritional science against the economic interests of the industry.
They move deliberately, gathering evidence, commissioning studies, and opening dockets for public comment over years or decades. The memo from HealthSmart's meeting is a single data point in an ongoing effort to balance public health and commercial interest. The Stakes for Product Labeling
For consumers in the grocery aisle, the outcome of this debate is practical. It determines whether package labels provide useful data or deceptive marketing.
The core of the issue is what gets subtracted from the total carbohydrate count. When a label says "net carbs," it asks you to ignore a portion of the ingredients. For example, if a bar has 20 grams of total carbohydrates, 10 grams of fiber, and 5 grams of erythritol, a sugar alcohol, the net carb calculation subtracts the fiber and sugar alcohol to claim "5g Net Carbs" on the front of the package.
The scientific consensus is that dietary fiber is poorly absorbed and has minimal impact on blood sugar. Sugar alcohols are more complicated. Some, like erythritol, have a low glycemic impact. Others, like maltitol or sorbitol, can have a noticeable effect on blood sugar, though less than regular sugar. The debate that HealthSmart is engaging in could determine which of these ingredients qualify for subtraction.
If a company like HealthSmart successfully lobbies for a loose definition, it could allow more ingredients to be subtracted, leading to low net carb counts on processed foods that still produce a metabolic effect. If public health groups prevail, the FDA might ban the term "net carbs" altogether, forcing companies to display only the legally defined "Total Carbohydrate" value on the Nutrition Facts panel. Alternatively, regulators could establish a compromise, strictly defining which types of fiber and sugar alcohols can be subtracted.
For a person with Type 1 diabetes, an inaccurate carb count can make it difficult to calculate the correct insulin dose. For someone on a strict ketogenic diet, uncounted carbs can prevent them from achieving their desired metabolic state. For the average consumer trying to cut back on sugar, it is a matter of truth in labeling. The conversation documented in this FDA memo is an effort to write the rules governing those numbers. What to Expect Next
This story is ongoing. The August 2026 memo is a record of contact, not a final rule. Because this is part of a public regulatory process, consumers can follow docket FDA-2004-P-0021 on the Regulations.gov website to track future administrative steps.
Concrete milestones to watch for within that docket include: Look for new filings
First, look for more meeting memos or public comments. Rival companies, industry trade groups, or consumer advocates might request their own meetings with the FDA or submit written opinions in response to HealthSmart's push. Reading these documents provides a broader view of competing industry positions.